Viz Projects
1. BRCA1 Around the World
2. Olapareb: Adverse Events and QOL in BRCA
2. Olapareb: Adverse Events and QOL in BRCA
A plain language interpretation of the BRCA1 data as a subset derived from the paper: Rebbeck, Timothy R et al. “Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.” Human mutation vol. 39,5 (2018): 593-620. doi:10.1002/humu.23406
2. Olapareb: Adverse Events and QOL in BRCA
2. Olapareb: Adverse Events and QOL in BRCA
2. Olapareb: Adverse Events and QOL in BRCA
An interpretation of Table 1 Incidence of the most common AEs occurring in >10% of patients from the paper: Robson, M E et al. “OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer.” Annals of oncology : official journal of the European Society for Medical Oncology vol. 30,4 (2019): 558-566.
3. Global Cardiovascular Disease: What are the risks?
3. Global Cardiovascular Disease: What are the risks?
3. Global Cardiovascular Disease: What are the risks?
This data story explored the causes of cardiovascular disease as the leading cause of death globally.
4. Illinois Cancer and Pollution
3. Global Cardiovascular Disease: What are the risks?
3. Global Cardiovascular Disease: What are the risks?
This project looked at the location of waste sites in Illinois (where I lived for 20 years) and cancer rates.